159 related articles for article (PubMed ID: 29849584)
1. Serum ADAMTS-13 Levels as an Indicator of Portal Vein Thrombosis.
Mikuła T; Kozłowska J; Stańczak W; Sapuła M; Różyk A; Wiercińska-Drapało A
Gastroenterol Res Pract; 2018; 2018():3287491. PubMed ID: 29849584
[TBL] [Abstract][Full Text] [Related]
2. Presence of portal vein thrombosis in liver cirrhosis is strongly associated with low levels of ADAMTS-13: a pilot study.
Lancellotti S; Basso M; Veca V; Sacco M; Riccardi L; Pompili M; De Cristofaro R
Intern Emerg Med; 2016 Oct; 11(7):959-67. PubMed ID: 27220954
[TBL] [Abstract][Full Text] [Related]
3. ADAMTS-13: A Prognostic Biomarker for Portal Vein Thrombosis in Japanese Patients with Liver Cirrhosis.
Suzuki J; Namisaki T; Takya H; Kaji K; Nishimura N; Shibamoto A; Asada S; Kubo T; Iwai S; Tomooka F; Takeda S; Koizumi A; Tanaka M; Matsuda T; Inoue T; Fujimoto Y; Tsuji Y; Fujinaga Y; Sato S; Kitagawa K; Kawaratani H; Akahane T; Mitoro A; Matsumoto M; Asada K; Yoshiji H
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473925
[TBL] [Abstract][Full Text] [Related]
4. ADAMTS-13/von Willebrand factor ratio: A prognostic biomarker for portal vein thrombosis in compensated cirrhosis. A prospective observational study.
Sacco M; Tardugno M; Lancellotti S; Ferretti A; Ponziani FR; Riccardi L; Zocco MA; De Magistris A; Santopaolo F; Pompili M; De Cristofaro R
Dig Liver Dis; 2022 Dec; 54(12):1672-1680. PubMed ID: 35778228
[TBL] [Abstract][Full Text] [Related]
5. Increased platelet ratio in patients with decompensated cirrhosis indicates a higher risk of portal vein thrombosis.
Zanetto A; Campello E; Burra P; Senzolo M; Simioni P
Liver Int; 2023 Jan; 43(1):155-159. PubMed ID: 36156848
[TBL] [Abstract][Full Text] [Related]
6. Correlation of routinely used coagulation parameters and presence of portal vein thrombosis in patients with liver cirrhosis.
Weber A; Krebs S; Lenhardt C; Wagenpfeil S; Schmid RM; Schulte-Frohlinde E
Hepatol Res; 2009 Sep; 39(9):882-7. PubMed ID: 19619258
[TBL] [Abstract][Full Text] [Related]
7. Anticoagulation in Cirrhosis and Portal Vein Thrombosis Is Safe and Improves Prognosis in Advanced Cirrhosis.
Noronha Ferreira C; Reis D; Cortez-Pinto H; Tato Marinho R; Gonçalves A; Palma S; Leite I; Rodrigues T; Pedro AJ; Alexandrino P; Serejo F; Sobral Dias M; Ferreira P; Vasconcelos M; Damião F; Xavier Brito L; Baldaia C; Fatela N; Ramalho F; Velosa J
Dig Dis Sci; 2019 Sep; 64(9):2671-2683. PubMed ID: 30852769
[TBL] [Abstract][Full Text] [Related]
8. [Clinical features of liver cirrhosis complicated by portal vein thrombosis and related risk factors].
Lin GS; Xu Q; Zhao SY; Zhang YX
Zhonghua Gan Zang Bing Za Zhi; 2016 Jul; 24(7):513-517. PubMed ID: 27784429
[No Abstract] [Full Text] [Related]
9. Serum omentin and vaspin levels in cirrhotic patients with and without portal vein thrombosis.
Kukla M; Waluga M; Żorniak M; Berdowska A; Wosiewicz P; Sawczyn T; Bułdak RJ; Ochman M; Ziora K; Krzemiński T; Hartleb M
World J Gastroenterol; 2017 Apr; 23(14):2613-2624. PubMed ID: 28465646
[TBL] [Abstract][Full Text] [Related]
10. De-novo portal vein thrombosis in liver cirrhosis: risk factors and correlation with the Model for End-stage Liver Disease scoring system.
Abdel-Razik A; Mousa N; Elhelaly R; Tawfik A
Eur J Gastroenterol Hepatol; 2015 May; 27(5):585-92. PubMed ID: 25769098
[TBL] [Abstract][Full Text] [Related]
11. Resistance to thrombomodulin is associated with de novo portal vein thrombosis and low survival in patients with cirrhosis.
La Mura V; Tripodi A; Tosetti G; Cavallaro F; Chantarangkul V; Colombo M; Primignani M
Liver Int; 2016 Sep; 36(9):1322-30. PubMed ID: 26854258
[TBL] [Abstract][Full Text] [Related]
12. Incidence, predictive factors and clinical significance of development of portal vein thrombosis in cirrhosis: A prospective study.
Noronha Ferreira C; Marinho RT; Cortez-Pinto H; Ferreira P; Dias MS; Vasconcelos M; Alexandrino P; Serejo F; Pedro AJ; Gonçalves A; Palma S; Leite I; Reis D; Damião F; Valente A; Xavier Brito L; Baldaia C; Fatela N; Ramalho F; Velosa J
Liver Int; 2019 Aug; 39(8):1459-1467. PubMed ID: 31021512
[TBL] [Abstract][Full Text] [Related]
13. High-density lipoprotein cholesterol for the prediction of mortality in cirrhosis with portal vein thrombosis: a retrospective study.
Gao B; Xiao J; Zhang M; Zhang F; Zhang W; Yang J; He J; Liu Y; Zou X; Xu P; Zhuge Y
Lipids Health Dis; 2019 Mar; 18(1):79. PubMed ID: 30927926
[TBL] [Abstract][Full Text] [Related]
14. Procoagulant imbalance aggravated with falling liver function reserve, but not associated with the presence of portal vein thrombosis in cirrhosis.
Tang W; Wang Y; Zhao X; Wang X; Zhang T; Ou X; Shou W; You H; Jia J
Eur J Gastroenterol Hepatol; 2015 Jun; 27(6):672-8. PubMed ID: 25923942
[TBL] [Abstract][Full Text] [Related]
15. Potential utility of a multi-component coagulation factor panel to calculate MELD scores and assess the risk of portal vein thrombosis in chronic liver disease.
Lewis CS; Bari K; Xie C; Sherman KE; Vasse M; Van Dreden P; Bogdanov VY
BMC Gastroenterol; 2023 Mar; 23(1):65. PubMed ID: 36894870
[TBL] [Abstract][Full Text] [Related]
16. Nontumorous Portal Vein Thrombosis in Liver Cirrhosis: Possible Role of β-Blockers.
Giannitrapani L; Granà W; Licata A; Schiavone C; Montalto G; Soresi M
Med Princ Pract; 2018; 27(5):466-471. PubMed ID: 30107378
[TBL] [Abstract][Full Text] [Related]
17. Portal vein thrombosis compromises the performance of MELD and MELD-Na scores in patients with cirrhosis.
Ouyang R; Li H; Tan W; Wang X; Zheng X; Huang Y; Meng Z; Gao Y; Qian Z; Liu F; Lu X; Shi Y; Shang J; Liu J; Deng G; Zheng Y; Yan H; Jiang X; Zhang Y; Qiao L; Zhou Y; Hou Y; Xiong Y; Chen J; Luo S; Gao N; Ji L; Li J; Zheng R; Ren H; Wang H; Zhong G; Li B; Chen J
J Gastroenterol Hepatol; 2023 Jan; 38(1):129-137. PubMed ID: 36345143
[TBL] [Abstract][Full Text] [Related]
18. The Impact of Portal Vein Thrombosis on the Prognosis of Patients With Cirrhosis: A Retrospective Propensity-Score Matched Study.
Chen Z; Ran T; Cao H; Xu F; Zhou ZH; He S
Front Med (Lausanne); 2021; 8():685944. PubMed ID: 34262917
[No Abstract] [Full Text] [Related]
19. Portal vein thrombosis in cirrhosis.
Raja K; Jacob M; Asthana S
J Clin Exp Hepatol; 2014 Dec; 4(4):320-31. PubMed ID: 25755579
[TBL] [Abstract][Full Text] [Related]
20. Portal vein thrombosis is not associated with increased mortality among patients with cirrhosis.
Berry K; Taylor J; Liou IW; Ioannou GN
Clin Gastroenterol Hepatol; 2015 Mar; 13(3):585-93. PubMed ID: 25459555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
